Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sample 2024-07-05
  2. Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients 2024-05-16
  3. Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy 2022-11-01

Studies

4 studies carry this tag.

Date range

2021 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Alzheimer's research & therapy 1
  • Brain : a journal of neurology 1
  • Brain communications 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sample

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-07-05 Biomarkers

    In the CU, amyloid-negative (A-) subset, plasma p-tau217 levels increased modestly with age but were unaffected by body mass index and kidney function.

  2. Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer's research & therapy 2024-05-16 Biomarkers

    Plasma NfL and GFAP predict cognitive decline in a similar manner to traditional imaging techniques in amyloid-positive MCI patients.

  3. Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Brain : a journal of neurology 2022-11-01 Biomarkers

    Phosphorylated Tau181 (pTau181) in CSF and recently in plasma has been associated with Alzheimer's disease.

  4. Association of plasma P-tau181 with memory decline in non-demented adults

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. Brain communications 2021-06-14 Biomarkers

    Mixed-effect models assessed rates of memory decline in relation to baseline plasma p-tau181, and whether plasma p-tau181 significantly predicted memory decline beyond widely available clinical and genetic data (age, sex, years of education, cardiovascular and metabolic conditions, and APOE ε 4 status).

All topic tags with their study counts